Aquestive Therapeutics, Inc. AQST Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s other noncash income (expense)?
- Aquestive Therapeutics, Inc. (AQST) reported other noncash income (expense) of -$6K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s other noncash income (expense) changed year-over-year?
- Aquestive Therapeutics, Inc.'s other noncash income (expense) increased by 87.0% year-over-year, from -$46K to -$6K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s other noncash income (expense)?
- Over 2 years (2021 to 2025), Aquestive Therapeutics, Inc.'s other noncash income (expense) has grown at a -94.2% compound annual growth rate (CAGR), from $299K to -$1K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.